Medicamen Biotech Limited (MEDICAMEQ) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.018x

Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has a cash flow conversion efficiency ratio of 0.018x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs36.46 Million ≈ $394.32K USD) by net assets (Rs2.00 Billion ≈ $21.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MEDICAMEQ cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Medicamen Biotech Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Medicamen Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Medicamen Biotech Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicamen Biotech Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LMS Co. Ltd KQ:073110	-0.044x
Cannindah Resources Ltd AU:CAE	-0.041x
Sjm Holdings KO:025530	0.030x
Kartal Yenilenebilir Enerji Uretim AS IS:KARYE	-0.059x
SK Chemicals Co Ltd Pref KO:28513K	0.016x
Ocean Group JSC VN:OGC	0.070x
New Advanced Electronics Technologies Co Ltd TWO:3465	-0.107x
Co2 Capsol AS OL:CAPSL	-0.204x

Annual Cash Flow Conversion Efficiency for Medicamen Biotech Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Medicamen Biotech Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Medicamen Biotech Limited (MEDICAMEQ) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.13 Billion ≈ $23.01 Million	Rs-98.59 Million ≈ $-1.07 Million	-0.046x	-42.21%
2024-03-31	Rs2.07 Billion ≈ $22.38 Million	Rs-67.44 Million ≈ $-729.32K	-0.033x	-0.14%
2023-03-31	Rs1.93 Billion ≈ $20.92 Million	Rs-62.93 Million ≈ $-680.54K	-0.033x	-215.97%
2022-03-31	Rs1.46 Billion ≈ $15.84 Million	Rs41.09 Million ≈ $444.38K	0.028x	-70.81%
2021-03-31	Rs1.33 Billion ≈ $14.37 Million	Rs127.72 Million ≈ $1.38 Million	0.096x	-9.00%
2020-03-31	Rs1.21 Billion ≈ $13.11 Million	Rs128.02 Million ≈ $1.38 Million	0.106x	+112.74%
2019-03-31	Rs866.34 Million ≈ $9.37 Million	Rs43.01 Million ≈ $465.12K	0.050x	+167.91%
2018-03-31	Rs746.08 Million ≈ $8.07 Million	Rs-54.54 Million ≈ $-589.80K	-0.073x	-154.50%
2017-03-31	Rs267.81 Million ≈ $2.90 Million	Rs35.92 Million ≈ $388.49K	0.134x	-61.29%
2016-03-31	Rs179.09 Million ≈ $1.94 Million	Rs62.06 Million ≈ $671.13K	0.347x	+281.86%
2015-03-31	Rs171.85 Million ≈ $1.86 Million	Rs-32.74 Million ≈ $-354.11K	-0.191x	-161.32%
2014-03-31	Rs165.38 Million ≈ $1.79 Million	Rs51.39 Million ≈ $555.74K	0.311x	+410.42%
2013-03-31	Rs157.17 Million ≈ $1.70 Million	Rs-15.73 Million ≈ $-170.14K	-0.100x	+42.34%
2012-03-31	Rs201.01 Million ≈ $2.17 Million	Rs-34.90 Million ≈ $-377.38K	-0.174x	-131.21%
2011-03-31	Rs204.12 Million ≈ $2.21 Million	Rs113.52 Million ≈ $1.23 Million	0.556x	+722.44%
2010-03-31	Rs162.61 Million ≈ $1.76 Million	Rs11.00 Million ≈ $118.92K	0.068x	-89.45%
2009-03-31	Rs129.60 Million ≈ $1.40 Million	Rs83.07 Million ≈ $898.33K	0.641x	+227.09%
2008-03-31	Rs115.83 Million ≈ $1.25 Million	Rs22.70 Million ≈ $245.46K	0.196x	+662.67%
2007-03-31	Rs100.73 Million ≈ $1.09 Million	Rs2.59 Million ≈ $27.99K	0.026x	-91.54%
2006-03-31	Rs85.67 Million ≈ $926.49K	Rs26.02 Million ≈ $281.45K	0.304x	--

About Medicamen Biotech Limited

NSE:MEDICAMEQ India Drug Manufacturers - Specialty & Generic

Market Cap

$33.41 Million

Rs3.09 Billion INR

Market Cap Rank

#23456 Global

#1296 in India

Share Price

Rs227.80

Change (1 day)

+1.13%

52-Week Range

Rs223.30 - Rs421.60

All Time High

Rs1195.88